Ryzumvi
NDC 83368-075, phentolamine mesylate, solution/ drops, from Oyster Point Pharma, Inc..
- Product NDC
- 83368-075
- Status
- Listed
- Labeler
- Oyster Point Pharma, Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217064
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83368-075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHENTOLAMINE MESYLATE10 mg/mL
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83368-075-30 | 83368007530 | 6 POUCH in 1 CARTON (83368-075-30) / 5 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE |
| 83368-075-31 | 83368007531 | 1 POUCH in 1 CARTON (83368-075-31) / 5 VIAL, SINGLE-USE in 1 POUCH / .2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/96bb1e53-c2cc-4e60-a21a-db0269c371bf
Use it
Look up 83368-075 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83368-075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83368-075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.